Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Erika Viel"'
Autor:
Jean-David Fumet, Mark Wickre, Jean-Philippe Jacquot, Marie-Helene Bizollon, Adrien Melis, André Vanoli, Erika Viel
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-5 (2018)
Abstract Background Metastatic breast cancer (MBC) rest an incurably disease associated with bad prognosis and a median overall survival of 23–31 months. There are several treatment options including chemotherapy and sometimes endocrine therapy. Cu
Externí odkaz:
https://doaj.org/article/d8505e67fd594c77879a59314759ddb5
Autor:
Camille Grandclement, Jean René Pallandre, Séverine Valmary Degano, Erika Viel, Adeline Bouard, Jérémy Balland, Jean-Paul Rémy-Martin, Benoit Simon, Alain Rouleau, Wilfrid Boireau, Michael Klagsbrun, Christophe Ferrand, Christophe Borg
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e20444 (2011)
Neuropilins, initially characterized as neuronal receptors, act as co-receptors for cancer related growth factors and were recently involved in several signaling pathways leading to cytoskeletal organization, angiogenesis and cancer progression. Then
Externí odkaz:
https://doaj.org/article/4757f056c49c4d5596750aaac0a90a74
Autor:
Laurie Rambach, Erika Viel, Djamel Harami, Benjamin Schipman, David Truong, François Guinet, André Vanoli
Publikováno v:
Med Acupunct
Background: Chemotherapy-induced peripheral neuropathy (CIPN) can adversely affect completion of systemic anticancer treatment and cause long-term morbidity. To date, its physiopathology remains unclear, and treatments are rare and poorly performed.
Autor:
François Chaumier, David Truong, Marilène Filbet, Djamel Harami, André Vanoli, Erika Viel, Colombe Tricou
Publikováno v:
International Journal of Palliative Nursing. 26:64-69
Background: Dedicated identified palliative care beds (IPCB) are unique to France. Aims: This study aimed to assess their use and advantages in a medical oncology department of a private provincial hospital. Findings: Of the last 100 patients who die
Autor:
Marie-Helene Bizollon, Jean-David Fumet, Adrien Melis, Erika Viel, André Vanoli, Mark Wickre, Jean-Philippe Jacquot
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-5 (2018)
BMC Cancer
BMC Cancer
Background Metastatic breast cancer (MBC) rest an incurably disease associated with bad prognosis and a median overall survival of 23–31 months. There are several treatment options including chemotherapy and sometimes endocrine therapy. Currently,
Autor:
Marie Potier-Cartereau, Imane Soubai, Carina Rua, Maxime Guéguinou, Catherine Barbe, Aurélie Chantôme, Philippe Bougnoux, Erika Viel, Chantal Barin-Le Guellec, Christophe Vandier
Publikováno v:
Clinical Cancer Research
Clinical Cancer Research, American Association for Cancer Research, 2018, 24 (21), pp.5313-5320. ⟨10.1158/1078-0432.CCR-18-0870⟩
Clinical Cancer Research, American Association for Cancer Research, 2018, 24 (21), pp.5313-5320. ⟨10.1158/1078-0432.CCR-18-0870⟩
Purpose: Taxane-induced peripheral neuropathy is a common side effect induced by anticancer agents, and no drug capable of preventing its occurrence or ameliorating its long-term course has been identified. The physiology of taxane neuropathy is not
Autor:
Loic Chaigneau, Hamadi Almotlak, Elsa Curtit, Eleonor Fanton, Elsa Kalbacher, Régis Aubry, Antoine Thiery-Vuillemnin, Xavier Pivot, Erion Dobi, Erika Viel, Cristian Villanueva
Publikováno v:
Supportive Care in Cancer. 21:405-412
The treatment of patients with advanced cancer is becoming increasingly aggressive near the end of life, whereas poor literature is available. This study analyzes the management of patients with a solid cancer in their last 3 months of life in the Ce
Publikováno v:
Bulletin du Cancer. 99:181-189
EGFR may be considered as an old target, which can be inhibited both by monoclonal antibodies and tyrosine kinase inhibitors. Those molecular targeted strategies are now approved in a wild range of tumors: colorectal cancer, lung cancer, pancreatic c
Autor:
Elsa Kalbacher, Erion Dobi, Jean-Yves Blay, Erika Viel, Laura Mansi, Elsa Curtit, Loic Chaigneau, Xavier Pivot, Thierry Nguyen
Publikováno v:
Bulletin du Cancer. 99:191-197
Resume Les connaissances scientifiques sur les tumeurs stromales gastro-intestinales (GIST) ont enormement progresse ces dix dernieres annees. Les mutations activatrices de KIT , bases moleculaires de la transformation oncogenique, ont ete identifiee
Autor:
Christiane Mougin, Christophe Ferrand, Séverine Valmary-Degano, Sandrine Magnin, Christophe Borg, Marthe Bigand, Benoit Girardo, Alice Baraquin, Jean-Luc Prétet, Erika Viel, Bernadette Kantelip
Publikováno v:
Journal of Molecular Diagnostics
Journal of Molecular Diagnostics, American Society for Investigative Pathology (ASIP), 2011, 13 (5), pp.485-492. 〈10.1016/j.jmoldx.2011.05.010〉
Journal of Molecular Diagnostics, American Society for Investigative Pathology (ASIP), 2011, 13 (5), pp.485-492. ⟨10.1016/j.jmoldx.2011.05.010⟩
Journal of Molecular Diagnostics, American Society for Investigative Pathology (ASIP), 2011, 13 (5), pp.485-492. 〈10.1016/j.jmoldx.2011.05.010〉
Journal of Molecular Diagnostics, American Society for Investigative Pathology (ASIP), 2011, 13 (5), pp.485-492. ⟨10.1016/j.jmoldx.2011.05.010⟩
International audience; The analysis of KRAS mutations has become a prerequisite for anti-epidermal growth factor receptor therapy in patients with metastatic colorectal cancers. KRAS mutations are associated with resistance to treatment by monoclona